Abstract
WhetherHelicobacter pylori is causally linked to dyspepsia remains controversial. The aims of this study were to assess in healthy blood donors the prevalence of dyspepsia and dyspepsia subgroups, determine ifH. pylori is associated with different categories of dyspeptic symptoms, and evaluate the association between dyspepsia and nicotine, alcohol, and analgesic use. Consecutive blood donors (N=180) who had no clinical evidence of organic disease were included. Abdominal symptoms were measured by means of a standardized questionnaire that has been previously validated. Subjects with dyspepsia (defined as pain localized to the upper abdomen) were further subdivided into those with ulcer-like, dysmotility-like, reflux-like, or nonspecific dyspepsia. A total of 65 subjects reported abdominal pain or discomfort during the prior 12 months [36.1%, 95% confidence interval (CI) 29.1–43.1]; 44 subjects (24.4%, 95% CI 18.2–30.7) had dyspepsia. Dysmotility-like, reflux-like, and ulcer-like symptoms were reported by 19.4% (95% CI 13.7–25.2), 17.2% (95% CI 11.7–22.7), and 16.7% (95% CI 11.2–22.1) of subjects with dyspepsia, respectively. Fifty-seven subjects (31.7%, 95% CI 24.9–38.5) wereH. pylori positive; 26% of subjects withH. pylori and 24% withoutH. pylori had dyspepsia (P>0.50). The seroprevalence ofH. pylori was also similar among the different categories of dyspepsia. We conclude that infection withH. pylori is not associated with abdominal complaints in otherwise healthy subjects.
Similar content being viewed by others
References
Tibblin G: Introduction to the epidemiology of dyspepsia. Scand J Gastroenterol Suppl 109:29–33, 1985
Jones RH, Lydeard S: Prevalence of symptoms of dyspepsia in the community. Br Med J 298:30–32, 1989
Thompson WG, Heaton KW: Functional bowel disorders in apparently healthy people. Gastroenterology 79:283–288, 1980
Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ: Dyspepsia and dyspepsia subgroups: A population-based study. Gastroenterology 102:1259–1268, 1992
Talley NJ, Phillips SF: Non-ulcer dyspepsia: Potential causes and pathophysiology. Ann Intern Med 108:865–879, 1988
Holtmann G, Goebell H: Ursachen der funktionellen Dyspepsie. Dtsch Med Wochenschr 117:1029–1034, 1992
Talley NJ: Chronic (non-specific) gastritis. Dig Dis Sci 347:61–75, 1989
Morris A, Nicholson G: Ingestion of campylobacter pyloridis causing gastritis and raised fasting pH. Am J Gastroenterol 82:192–199, 1987
Blaser MJ: Hypotheses on the pathogeneses and natural history ofHelicobacter pylori-induced inflammation. Gastroenterology 102:720–727, 1992
Dooley CP, Cohen H, Fitzgibbons P, Bauer M, Appleman MD, Perez-Perez GJ, Blaser MJ: Prevalence ofHelicobacter pylori and histologic gastritis in asymptomatic persons. N Engl J Med 321:1562–1566, 1989
Blaser MJ: Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease. Gastroenterology 93:371–383, 1987
Andersen LP, Elsborg L, Justesen T:Campylobacter pylori in peptic ulcer disease. III. Symptoms and paraclinical and epidemiologic findings. Scand J Gastroenterol 23:347–350, 1988
Börsch G, Schmidt G, Wegener M, Sandmann M, Adamek R, Leverkus F, Reitemeyer E:Campylobacter pylori: Prospective analysis of clinical and histological factors associated with colonization of the upper gastrointestinal tract. Eur J Clin Invest 18:133–138, 1988
Collins JS, Knill-Jones RP, Sloan JM, Watt PCH, Hamilton PW, Crean GP, Love AHG: Comparison of symptoms between non-ulcer dyspepsia patients positive and negative forC. pylori using a single bias computer system for history taking. Klin Wochenschr 67(suppl 18):11–12, 1989
Guerre J, Berthe Y, Chaussade S, Merite F, Gaudric M, Tulliez M, Deslignieres S, Zone A: HasCampylobacter pylori gastritis a specific clinical symptomatology. Klin Wochenschr 67(suppl 18):25–26, 1989
Loffeld RJ, Potters HV, Arends JW, Stobberingh E, Flendrig JA, van Spreeuwel JP:Campylobacter associated gastritis in patients with non-ulcer dyspepsia. J Clin Pathol 41:85–88, 1988
Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1:1311–1315, 1984
Rathbone BJ, Wyatt J, Heatley RV: Symptomatology inC. pylori positive and negative nonulcer dyspepsia. Gut 29:A1473, 1988
Rokkas T, Pursey C, Uzoechina E, Dorrington L, Simmons NA, Filipe MI, Sladen GE:Campylobacter pylori and non-ulcer dyspepsia. Am J Gastroenterol 82:1149–1152, 1987
Sobala GM, Dixon MF, Axon ATR:H. pylori is not associated with a distinct dyspeptic syndrome. Gut 30:A733, 1989
Landini MP, Varoli O, Tucci A, Paparo GF, Corinaldesi R, Zoccoli G, Lalli AA, La Placa M: Antibodies toCampylobacter pylori in patients with idiopathic dyspepsia. Microbiologica 12:181–188, 1989
Collins JS, Knill Jones RP, Sloan JM, Hamilton PW, Watt PC, Crean GP, Love AH: A comparison of symptoms between non-ulcer dyspepsia patients positive and negative forHelicobacter pylori. Ulster Med J 60:21–27, 1991
Goh KL, Parasakthi N, Peh SC, Wong NW, Lo YL, Puthucheary SD:Helicobacter pylori infection and non-ulcer dyspepsia: The effect of treatment with colloidal bismuth subcitrate. Scand J Gastroenterol 26:1123–1131, 1991
Strauss RM, Wang TC, Kelsey PB, Campton CC, Ferraro MT, Perez-Perez G, Blaser MJ: Association ofHelicobacter pylori infection with dyspeptic symptoms in patients under-going gastroduodenoscopy. Am J Med 89:464–469, 1990
Talley NJ, Phillips SF, Bruce B, Twomey CK, Zinsmeister AR, Melton LJ III: Relation among personality and symptoms on nonulcer dyspepsia and the irritable bowel syndrome. Gastroenterology 99:327–333, 1990
Whitehead WE, Bosmajian L, Zorderman AB, Costa PT, Schuster MM: Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples. Gastroenterology 95:709–714, 1988
Sitas F, Forman D, Yarnell JWG, Burr ML, Elwood PC, Pedley S, Marks KJ:Helicobacter pylori rates in relation to age and social class in a population of Welsh men. Gut 32:25–28, 1991
Colin-Jones DG, Bloom B, Bodemar G, Crean G, Freston J, Gigler R, Malagelada J, Nyrén O, Petersen H, Piper D: Management of dyspepsia: report of a working party. Lancet 1:576–579, 1988
Talley NJ, Colin-Jones D, Koch KL, Koch M, Nyrén O, Stanghellini V: Functional dyspepsia: A classification with guidelines for diagnosis and management. Gastroenterol Int 4:145–160, 1991
Petersen WL:Helicobacter pylori and peptic ulcer disease. N Engl J Med 324:1043–1048, 1991
Blaser MJ, Duncan DJ: Human serum antibody response toCampylobacter jejuni infection as measured in an enzyme linked immunoabsorbent assay. Infect Immun 33:292–298, 1984
Talley NJ, Newell DG, Ormand JE, Carpenter HA, Wilson WR, Zinsmeister AR, Perez-Perez GI, Blaser MJ: Serodiagnosis ofHelicobacter pylori: Comparison of enzyme-linked immunosorbent assay. J Clin Microbiol 29:1635–1639, 1991
Talley NJ, Phillips SF, Melton J, Wiltgen C, Zinsmeister AR: A patient questionnaire to identify bowel disease. Ann Intern Med 111:671–674, 1989
Koran LM: The reliability of clinical methods, data and judgments. N Engl J Med 293:642–646, 1975
Drossman DA, Thompson WG, Talley NJ, Funch-Jensen P, Janssens J, Whitehead WE: Identification of subgroups of functional gastrointestinal disorders. Gastroenterology 3:159–172, 1990
Talley NJ, Piper DW: Comparison of the clinical features and illness behaviour of patients presenting with dyspepsia of unknown cause (essential dyspepsia) and organic disease. Aust NZ J Med 16:352–359, 1986
Fleiss JL: Statistical Methods for Rates and Proportions. New York, Wiley, 1981, pp 29–30
Gardner M, Altman DG: Calculating confidence intervals for proportions and their differences.In Statistics with Confidence—Confidence Intervals and Statistical Guidelines. Gardner M, Altman DG (eds). London, 1991, pp 28–33
Atkinson AC: A note on the generalized information criterion for choice of a model. Biomet 67:413–418, 1980
SAS Institute Inc. SAS/STAT User's Guide, Release 6.03. Cary, North Carolina, SAS Institute, 1988
Banke L: Ulcumygdommers epidemiologi. Kobenhavn, F.A.D.L.'s Forlag, 1975
Hollnagel H, Norrelund N, Larsen S: Marve-tarmsymptomer blandt 40-arige i Glostrup: En epidemiologisk undersogelse. Ugeskr Laeg 1982;144:267–273
Johnsen R, Straume B, Forde OH: Peptic ulcer and non-ulcer dyspepsia—a disease and a disorder. Scand J Prim Health Care 6:239–243, 1988
Harrison JD, Morris DL: Dyspepsia in coalminers and the general population: A comparative study. Br J Ind Med 46:428–429, 1989
Holcombe C, Omotara BA, Padonu MK, Bassi AP: The prevalence of symptoms of dyspepsia in north eastern Nigeria. A random community based survey. Trop Geogr Med 43:209–214, 1991
Ahmed N, Malur PR, Sankapal MN, Nagalotimath SJ: Prevalence ofCampylobacter pylori in non-ulcerative dyspepsia. Indian J Pathol Microbiol 34:247–252, 1991
Metcalf R, Youngs GR: Prevalence of symptoms of dyspepsia. BMJ 298:526–527, 1989
Jones R, Lydeard S: Prevalence of symptoms of dyspepsia in the community. BMJ 298:30–32, 1989
Weir RD, Backett EM: Studies of the epidemiology of peptic ulcer in a rural community: Prevalence and natural history of dyspepsia and peptic ulcer. Gut 9:75–83, 1968
Bernersen B, Johnsen R, Bostad L, Straume B, Sommer AI, Burhol PG: IsHelicobacter pylori the cause of dyspepsia? BMJ 304:1276–1279, 1992
Richter JE: Dyspepsia: Organic causes and differential characteristics from functional dyspepsia. Scand J Gastroenterol Suppl 182:11–16, 1991
Klauser AG, Voderholzer WA, Knesewitsch PA, Schindelbeck NE, Müller-Lissner SA: What is behind dyspepsia. Gastroenterology 100:A458, 1991
Blum AL, Armstrong D, Damman H, Fischer M, Greiner L, Haase W, Hogeboom-Verdegal A, Liszkay M, Stolte M, Sulser H, Simon B, Talicomp Study Group: The effect ofHelicobacter pylori on the healing and relapse of duodenal ulcer. Gastroenterology 98:A22, 1990
Shallcross TMJ, Rathbone BJ, Heatley RV:Campylobacter pylori and non-ulcer dyspepsia.In Campylobacter pylori and Gastroduodenal Disease. Rathbone RJ, Heatly RV (eds). Oxford, Blackwell Scientific, 1989, pp 155–166
Pettross CW, Appleman MD, Cohen H, Valenzuela JE, Chandrasoma P, Laine LA: Prevalence ofCampylobacter pylori and association with antral mucosal histology in subjects with and without gastrointestinal symptoms. Dig Dis Sci 33:649–653, 1988
Rauws EA, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GN:Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 94:33–40, 1988
Lambert JR, Dunn K, Borromeo M, Korman MG, Hansky J:Campylobacter pylori-a role in non-ulcer dyspepsia? Scand J Gastroenterol Suppl 160:7–13, 1989
Glupczynski Y, Burette A, Labbe M, Deprez C, De Reuck M, Deltenre M:Campylobacter pylori-associated gastritis: A double-blind placebo-controlled trial with amoxycillin. Am J Gastroenterol 83:365–372, 1988
Talley NJ: Drug treatment of functional dyspepsia. Scand J Gastroenterol Suppl 182:47–60, 1991
Vaira D, Holton J, Ainley C, Falzon M, Osborn J, D'Anna L, Romanos A, Chandrakumaran K, McNeil I: Double blind trial of colloidal bismuth subcitrate versus placebo inHelicobacter pylori positive patients with non-ulcer dyspepsia. Ital J Gastroenterol 24:400–404, 1992
Rokkas T, Pursey C, Uzoechina E, Dorrington L, Simmons NA, Filipe MI, Sladen GE: Non-ulcer dyspepsia and short term De-Nol therapy: A placebo controlled trial with particular reference to the role ofCampylobacter pylori. Gut 29:1386–1391, 1988
Dill S, Payne-James JJ, Misiewicz JJ, Grimble GK, McSwiggan D, Pathak K, Wood AJ, Scrimgeous CM, Rennie MJ: Evaluation of the13C-urea breath test in the detection ofHelicobacter pylori and in monitoring the effect of tripotassium dicitrobismuthate in non ulcer dyspepsia. Gut 31:1237–1241, 1990
McNulty CA, Gearty JC, Crump B, Davis M, Donovan IA, Melikian V, Lister DM, Wise R:Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate. Br Med J (Clin Res Ed) 293:645–649, 1986
Patchett S, Beattie S, Leen E, Keane C, O'Morain C: EradicatingHelicobacter pylori and symptoms of non-ulcer dyspepsia. BMJ 303:1238–1240, 1991
Steering Committee of the Physicians' Health Study Group: Final report on the aspirin component of the ongoing physicians' health study. N Engl J Med 321:129–135, 1989
Author information
Authors and Affiliations
Additional information
Supported by a grant from Deutsche Forschungsgemeinschaft, grant number Ho 1193/3-1. Parts of this study were presented at the Annual Meeting of the American Gastroenterological Association in Boston, May 1993 and published as an abstract (Gastroenterology 104:A102, 1993).
Rights and permissions
About this article
Cite this article
Holtmann, G., Goebell, H., Holtmann, M. et al. Dyspepsia in healthy blood donors. Digest Dis Sci 39, 1090–1098 (1994). https://doi.org/10.1007/BF02087563
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02087563